Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Employment agrmnt
Appointed director
Consulting agrmnt
Director departure
|
|
THERALINK TECHNOLOGIES, INC. (OBMP)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 09/26/2022 |
4
| Schwartz Matthew Wilson (Director) has filed a Form 4 on THERALINK TECHNOLOGIES, INC.|
Txns:
| Acquired convertible notes
@ $0.0048, valued at
$0
Acquired 4,201,681 warrants
@ $0.0048, valued at
$20.2k
Granted 5,191,080 options to buy
@ $0.0036, valued at
$18.7k
|
|
| 09/22/2022 |
4
| FORS YVONNE (Director) has filed a Form 4 on THERALINK TECHNOLOGIES, INC.|
Txns:
| Granted 6,488,851 options to buy
@ $0.0036, valued at
$23.4k
|
|
| 09/21/2022 |
4
| Busch Jeffrey (Chairman of the Board) has filed a Form 4 on THERALINK TECHNOLOGIES, INC.|
Txns:
| Granted 469,738,712 options to buy
@ $0.0036, valued at
$1.7M
|
|
| 09/21/2022 |
4
| Chilcott, III Thomas E. (CFO) has filed a Form 4 on THERALINK TECHNOLOGIES, INC.|
Txns:
| Granted 94,545,096 options to buy
@ $0.0036, valued at
$340.4k
|
|
| 09/21/2022 |
4
| RUXIN MICHAEL I (CEO) has filed a Form 4 on THERALINK TECHNOLOGIES, INC.|
Txns:
| Granted 469,738,712 options to buy
@ $0.0036, valued at
$1.7M
|
|
| 06/22/2022 |
4
| Holley Danica (Director) has filed a Form 4 on THERALINK TECHNOLOGIES, INC.|
Txns:
| Acquired convertible notes
@ $0.0048, valued at
$0
Acquired 2,100,840 warrants
@ $0.0048, valued at
$10.1k
|
|
| 06/09/2020 |
4
| KUCHARCHUK ANDREW ALBERT (Director) has filed a Form 4 on OncBioMune Pharmaceuticals, Inc|
Txns:
| Granted 241 convertible preferred
@ $0.0001, valued at
$0 |
|
| 05/08/2020 |
4
| KUCHARCHUK ANDREW ALBERT (CEO and CFO) has filed a Form 4 on OncBioMune Pharmaceuticals, Inc|
Txns:
| Granted 283,334 shares
@ $0.06, valued at
$17k
|
|
| 05/08/2020 |
4
| HEAD JONATHAN FREDERICK (Director) has filed a Form 4 on OncBioMune Pharmaceuticals, Inc|
Txns:
| Granted 166,667 shares
@ $0.06, valued at
$10k
|
|
| 04/30/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/30/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/30/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/30/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/11/2018 |
4
| KUCHARCHUK ANDREW ALBERT (CFO) has filed a Form 4 on OncBioMune Pharmaceuticals, Inc|
Txns:
| Granted 3,000,000 options to buy
@ $0.0135, valued at
$40.5k
|
|
| 05/11/2018 |
4
| HEAD JONATHAN FREDERICK (CEO) has filed a Form 4 on OncBioMune Pharmaceuticals, Inc|
Txns:
| Granted 3,000,000 options to buy
@ $0.0135, valued at
$40.5k
|
|
| 05/11/2018 |
4
| Hoverman Daniel S. (Director) has filed a Form 4 on OncBioMune Pharmaceuticals, Inc|
Txns:
| Granted 3,000,000 options to buy
@ $0.0135, valued at
$40.5k
|
|
| 05/11/2018 |
4
| RICE CHARLES L JR (Director) has filed a Form 4 on OncBioMune Pharmaceuticals, Inc|
Txns:
| Granted 3,000,000 options to buy
@ $0.0135, valued at
$40.5k
|
|
| 04/20/2017 |
4
| RICE CHARLES L JR (Director) has filed a Form 4 on OncBioMune Pharmaceuticals, Inc |
| 04/20/2017 |
4
| Hoverman Daniel S. (Director) has filed a Form 4 on OncBioMune Pharmaceuticals, Inc |
| 04/20/2017 |
4
| KUCHARCHUK ANDREW ALBERT (CFO) has filed a Form 4 on OncBioMune Pharmaceuticals, Inc |
| 03/13/2017 |
4
| HEAD JONATHAN FREDERICK (CEO) has filed a Form 4 on OncBioMune Pharmaceuticals, Inc |
| 02/19/2016 |
4
| Hoverman Daniel S. (Director) has filed a Form 4 on OncBioMune Pharmaceuticals, Inc|
Txns:
| Granted 60,000 shares
@ $0 |
|
| 02/04/2016 |
4
| HEAD JONATHAN FREDERICK (CEO) has filed a Form 4 on OncBioMune Pharmaceuticals, Inc|
Txns:
| Granted 17,951,078 shares
@ $0
Sold 1,025,000 shares
@ $0.001, valued at
$1k
|
|
| 02/04/2016 |
4
| ELLIOT ROBERT LANGE JR (10% Owner) has filed a Form 4 on OncBioMune Pharmaceuticals, Inc|
Txns:
| Granted 17,951,079 shares
@ $0
Sold 1,025,000 shares
@ $0.001, valued at
$1k
|
|
| 02/04/2016 |
4
| KUCHARCHUK ANDREW ALBERT (CFO & President) has filed a Form 4 on OncBioMune Pharmaceuticals, Inc |
| 11/20/2015 |
4
| RICE CHARLES L JR (Director) has filed a Form 4 on OncBioMune Pharmaceuticals, Inc|
Txns:
| Granted 60,000 shares
@ $0 |
|
| 09/15/2015 |
4
| Leone Group, LLC (10% Owner) has filed a Form 4 on OncBioMune Pharmaceuticals, Inc|
Txns:
| Acquired 666,666 shares
@ $0.003, valued at
$2k
|
|
| 09/15/2015 |
4
| American Capital Ventures, Inc. (10% Owner) has filed a Form 4 on OncBioMune Pharmaceuticals, Inc|
Txns:
| Acquired 666,666 shares
@ $0.003, valued at
$2k
|
|
| 06/26/2015 |
4
| Leone Group, LLC (10% Owner) has filed a Form 4 on QUINT MEDIA INC.|
Txns:
| Sold 17,774,136 shares
@ $0.0001, valued at
$1.8k
Acquired 3,188,546 shares
@ $0.003, valued at
$9.6k
|
|
| 06/26/2015 |
4
| American Capital Ventures, Inc. (10% Owner) has filed a Form 4 on QUINT MEDIA INC.|
Txns:
| Sold 17,774,136 shares
@ $0.0001, valued at
$1.8k
Acquired 3,188,546 shares
@ $0.003, valued at
$9.6k
|
|
| 05/21/2015 |
4
| DIETRICH Constantin (CEO) has filed a Form 4 on QUINT MEDIA INC. |
| 04/17/2015 |
4
| DIETRICH Constantin (CEO) has filed a Form 4 on QUINT MEDIA INC. |
| 03/18/2015 |
4
| CARUSONE JOSEPH (VP, Investor Relations#) has filed a Form 4 on QUINT MEDIA INC. |
| 03/18/2015 |
4
| DIETRICH Constantin (CEO) has filed a Form 4 on QUINT MEDIA INC. |
|
|
|